Detailed Instructions: In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
Q: SECTION 1. SHORT TITLE.

This Act may be cited as ''Lali's Law''.

SEC. 2. OPIOID OVERDOSE REVERSAL MEDICATION ACCESS AND EDUCATION GRANT
PROGRAMS.

(a) Technical Clarification.--Effective as if included in the
enactment of the Children's Health Act of 2000 (Public Law 106-310),
section 3405(a) of such Act (114 Stat. 1221) is amended by striking
''Part E of title III'' and inserting ''Part E of title III of the
Public Health Service Act''.
(b) Amendment.--Title III of the Public Health Service Act is
amended by inserting after part D of such title (42 U.S.C. 254b et
seq.) the following new part E:

''PART E--OPIOID USE DISORDER

''SEC. 341. OPIOID OVERDOSE REVERSAL MEDICATION ACCESS AND EDUCATION
GRANT PROGRAMS.

''(a) Grants to States.--The Secretary may make grants to States
for--
''(1) developing standing orders for pharmacies regarding
opioid overdose reversal medication;
''(2) encouraging pharmacies to dispense opioid overdose
reversal medication pursuant to a standing order;
''(3) implementing best practices for persons authorized to
prescribe medication regarding--
''(A) prescribing opioids for the treatment of
chronic pain;
''(B) co-prescribing opioid overdose reversal
medication with opioids; and
''(C) discussing the purpose and administration of
opioid overdose reversal medication with patients;
''(4) developing or adapting training materials and methods
for persons authorized to prescribe or dispense medication to
use in educating the public regarding--
''(A) when and how to administer opioid overdose
reversal medication; and
''(B) steps to be taken after administering opioid
overdose reversal medication; and
''(5) educating the public regarding--
''(A) the public health benefits of opioid overdose
reversal medication; and
''(B) the availability of opioid overdose reversal
medication without a person-specific prescription.
''(b) Certain Requirement.--A grant may be made under this section
only if the State involved has authorized standing orders regarding
opioid overdose reversal medication.
''(c) Preference in Making Grants.--In making grants under this
section, the Secretary shall give preference to States that--
''(1) have not issued standing orders regarding opioid
overdose reversal medication;
''(2) authorize standing orders that permit community-based
organizations, substance abuse programs, or other nonprofit
entities to acquire, dispense, or administer opioid overdose
reversal medication;
''(3) authorize standing orders that permit police, fire,
or emergency medical services agencies to acquire and
administer opioid overdose reversal medication;
''(4) have a higher per capita rate of opioid overdoses
than other applicant States; or
''(5) meet any other criteria deemed appropriate by the
Secretary.
''(d) Grant Terms.--
''(1) Number.--A State may not receive more than one grant
under this section.
''(2) Period.--A grant under this section shall be for a
period of 3 years.
''(3) Amount.--A grant under this section may not exceed
$500,000.
''(4) Limitation.--A State may use not more than 20 percent
of a grant under this section for educating the public pursuant
to subsection (a)(5).
''(e) Applications.--To be eligible to receive a grant under this
section, a State shall submit an application to the Secretary in such
form and manner and containing such information as the Secretary may
require, including detailed proposed expenditures of grant funds.
''(f) Reporting.--Not later than 3 months after the Secretary
disburses the first grant payment to any State under this section and
every 6 months thereafter for 3 years, such State shall submit a report
to the Secretary that includes the following:
''(1) The name and ZIP Code of each pharmacy in the State
that dispenses opioid overdose reversal medication under a
standing order.
''(2) The total number of opioid overdose reversal
medication doses dispensed by each such pharmacy, specifying
how many were dispensed with or without a person-specific
prescription.
''(3) The number of pharmacists in the State who have
participated in training pursuant to subsection (a)(4).
''(g) Definitions.--In this section:
''(1) Opioid overdose reversal medication.--The term
'opioid overdose reversal medication' means any drug, including
naloxone, that--
''(A) blocks opioids from attaching to, but does
not itself activate, opioid receptors; or
''(B) inhibits the effects of opioids on opioid
receptors.
''(2) Standing order.--The term 'standing order' means a
document prepared by a person authorized to prescribe
medication that permits another person to acquire, dispense, or
administer medication without a person-specific prescription.
''(h) Authorization of Appropriations.--
''(1) In general.--To carry out this section, there is
authorized to be appropriated $5,000,000 for the period of
fiscal years 2017 through 2019.
''(2) Administrative costs.--Not more than 3 percent of the
amounts made available to carry out this section may be used by
the Secretary for administrative expenses of carrying out this
section.''.

SEC. 3. CUT-GO COMPLIANCE.

Subsection (f) of section 319D of the Public Health Service Act (42
U.S.C. 247d-4) is amended by inserting before the period at the end the
following: ''(except such dollar amount shall be reduced by $5,000,000
for fiscal year 2017)''.

Passed the House of Representatives May 12, 2016.

Attest:

KAREN L. HAAS,

Clerk.
A:
(This measure has not been amended since it was reported to the House on May 10, 2016. Lali's Law (Sec. 2) This bill amends the Public Health Service Act to permit the Department of Health and Human Services to make grants to states that allow standing orders (documents that allow a person to acquire, dispense, or administer a prescription medication without a person-specific prescription) for opioid overdose reversal medication (e.g., naloxone). (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.) Grants may be used for: developing standing orders for opioid overdose reversal medication for pharmacies; encouraging pharmacies to dispense medication pursuant to such a standing order; implementing best practices for prescribing opioids, prescribing opioid overdose reversal medication with opioids, and discussing opioid overdose reversal medication with patients; developing training for prescribers to use in educating the public on administration of opioid overdose reversal medication; and educating the public on the availability and public health benefits of opioid overdose reversal medication. States must report on pharmacies that dispense opioid overdose reversal medication under a standing order and the number of pharmacists trained in educating the public on administration of opioid overdose reversal medication. (Sec. 3) As an offset, this bill reduces the authorization of appropriations for Centers for Disease Control and Prevention facilities.